Author(s): Jaffe ES, Harris NL, Stein H, Vardiman JW
We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Referred From: https://www.nature.com/articles/s41375-022-01620-2
Author(s): Fitzpatrick PJ, Macko S
Author(s): Margo CE, Mulla ZD
Author(s): Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, et al.
Author(s): Dunbar SF, Linggood RM, Doppke KP
Author(s): Esik O, Ikeda H, Mukai K
Author(s): Smitt MC, Donaldson SS
Author(s): Stafford SL, Kozelsky TF, Garrity JA
Author(s): Lee SW, Suh CO, Kim GE
Author(s): Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, et al.
Author(s): Deeg HJ, Flournoy N, Sullivan KM
Author(s): Henk JM, Whitelocke RA, Warrington AP
Author(s): Suh CO, Shim SJ, Lee SW
Author(s): Goda JS, LeLW, Lapperriere NJ, Millar BA, Payne D, et al.
Author(s): Uno T, Isobe K, Shikama N
Author(s): Le QT, Eulau SM, George TI
Author(s): Tsang RW, Gospodarowicz MK, Pintilie M
Author(s): Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B